Bismuth-containing pharmaceutical compositions

Details Bismuth-containing pharmaceutical compositions Bismuth-containing pharmaceutical compositions

1987-12-10

1990-07-10

Griffin, Ronald W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514503, 514925, 514159, A61K 31715, A61K 3160, A61K 3129

Patent

active

049406957

ABSTRACT:
Pharmaceutical compositions suitable for oral administration comprising: (a) pharmaceutically-acceptable bismuth-containing agents such as bismuth subsalicylate; (b) pharmaceutically-acceptable non-ionic cellulose ether polymers such as methylcellulose; and (c) magnesium aluminum silicate. The ratio of bismuth to non-ionic cellulose ether polymer is greater than about 1.5:1. Compositions in the form of liquids containing water are preferred.
This invention also relates to methods for treating or preventing disturbances of the gastrointestinal tract in humans or lower animals by orally administering a composition of the present invention.

REFERENCES:
patent: 4801454 (1989-01-01), Coveney et al.
Handbook of Nonprescription Drugs, 8th Edition (American Pharmaceutical Association, Washington, D.C.; 1986); pp. 73-74.

Affiliated with

Also associated with

Rating

Bismuth-containing pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bismuth-containing pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bismuth-containing pharmaceutical compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1720939